116 related articles for article (PubMed ID: 15694492)
1. Expression and characterization of the ATP-binding domain of a malarial Plasmodium vivax gene homologous to the B-subunit of the bacterial topoisomerase DNA gyrase.
Khor V; Yowell C; Dame JB; Rowe TC
Mol Biochem Parasitol; 2005 Mar; 140(1):107-17. PubMed ID: 15694492
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit.
Dar MA; Sharma A; Mondal N; Dhar SK
Eukaryot Cell; 2007 Mar; 6(3):398-412. PubMed ID: 17220464
[TBL] [Abstract][Full Text] [Related]
3. Nuclear gyrB encodes a functional subunit of the Plasmodium falciparum gyrase that is involved in apicoplast DNA replication.
Raghu Ram EV; Kumar A; Biswas S; Kumar A; Chaubey S; Siddiqi MI; Habib S
Mol Biochem Parasitol; 2007 Jul; 154(1):30-9. PubMed ID: 17499371
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
Wu LC; Shahied SI
Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
[TBL] [Abstract][Full Text] [Related]
5. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
[TBL] [Abstract][Full Text] [Related]
7. Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
Garrido SS; Scatigno AC; Trovatti E; Carvalho DC; Marchetto R
J Pept Res; 2005 May; 65(5):502-11. PubMed ID: 15853944
[TBL] [Abstract][Full Text] [Related]
8. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
Scatigno AC; Garrido SS; Marchetto R
J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
[TBL] [Abstract][Full Text] [Related]
9. Dissection of the nucleotide cycle of B. subtilis DNA gyrase and its modulation by DNA.
Göttler T; Klostermeier D
J Mol Biol; 2007 Apr; 367(5):1392-404. PubMed ID: 17320901
[TBL] [Abstract][Full Text] [Related]
10. Identification, expression, modeled structure and serological characterization of Plasmodium vivax histone 2B.
Rawat DS; Sharma I; Jalah R; Lomash S; Kothekar V; Pasha ST; Sharma YD
Gene; 2004 Aug; 337():25-35. PubMed ID: 15276199
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium vivax: molecular cloning, expression and characterization of glutathione S-transferase.
Na BK; Kang JM; Kim TS; Sohn WM
Exp Parasitol; 2007 Aug; 116(4):414-8. PubMed ID: 17459379
[TBL] [Abstract][Full Text] [Related]
12. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
Hsu YH; Chung MW; Li TK
Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
[TBL] [Abstract][Full Text] [Related]
13. A unique 45-amino-acid region in the toprim domain of Plasmodium falciparum gyrase B is essential for its activity.
Dar A; Prusty D; Mondal N; Dhar SK
Eukaryot Cell; 2009 Nov; 8(11):1759-69. PubMed ID: 19700639
[TBL] [Abstract][Full Text] [Related]
14. First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.
Aubry A; Fisher LM; Jarlier V; Cambau E
Biochem Biophys Res Commun; 2006 Sep; 348(1):158-65. PubMed ID: 16876125
[TBL] [Abstract][Full Text] [Related]
15. Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties.
Kaiser A; Hammels I; Gottwald A; Nassar M; Zaghloul MS; Motaal BA; Hauber J; Hoerauf A
Bioorg Med Chem; 2007 Sep; 15(18):6200-7. PubMed ID: 17591443
[TBL] [Abstract][Full Text] [Related]
16. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
17. Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors.
Chavalitshewinkoon-Petmitr P; Worasing R; Wilairat P
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):733-8. PubMed ID: 12041546
[TBL] [Abstract][Full Text] [Related]
18. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74).
Alam MT; Bora H; Singh N; Sharma YD
Vaccine; 2008 Jul; 26(31):3787-94. PubMed ID: 18579264
[TBL] [Abstract][Full Text] [Related]
19. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
Kranz RG; Beckman DL; Foster-Hartnett D
FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum.
Weissig V; Vetro-Widenhouse TS; Rowe TC
DNA Cell Biol; 1997 Dec; 16(12):1483-92. PubMed ID: 9428797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
